Seaward Management Limited Partnership decreased its position in Danaher Corporation (NYSE:DHR) by 2.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 79,301 shares of the conglomerate’s stock after selling 2,194 shares during the period. Seaward Management Limited Partnership’s holdings in Danaher Corporation were worth $6,782,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the company. Peddock Capital Advisors LLC raised its stake in Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after buying an additional 181 shares in the last quarter. Proficio Capital Partners LLC raised its stake in Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after buying an additional 598 shares in the last quarter. ClariVest Asset Management LLC purchased a new stake in Danaher Corporation during the first quarter worth $157,000. Motco raised its stake in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock worth $158,000 after buying an additional 390 shares in the last quarter. Finally, Baystate Wealth Management LLC raised its stake in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock worth $163,000 after buying an additional 60 shares in the last quarter. Institutional investors own 76.12% of the company’s stock.

Shares of Danaher Corporation (NYSE DHR) traded up 0.22% during midday trading on Friday, hitting $81.09. 760,488 shares of the company traded hands. The stock has a market capitalization of $56.33 billion, a P/E ratio of 25.88 and a beta of 1.03. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.01. The company has a 50-day moving average price of $82.41 and a 200-day moving average price of $84.22.

Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same quarter in the prior year, the company posted $0.90 earnings per share. Danaher Corporation’s revenue for the quarter was up 6.3% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Seaward Management Limited Partnership Has $6.78 Million Stake in Danaher Corporation (DHR)” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/08/18/seaward-management-limited-partnership-has-6-78-million-stake-in-danaher-corporation-dhr.html.

DHR has been the subject of several research analyst reports. Wells Fargo & Company initiated coverage on shares of Danaher Corporation in a report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price objective for the company. BidaskClub lowered shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 1st. Jefferies Group LLC restated a “buy” rating and issued a $95.00 price objective on shares of Danaher Corporation in a report on Friday, August 4th. Zacks Investment Research lowered shares of Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. Finally, BTIG Research restated a “buy” rating and issued a $92.00 price objective on shares of Danaher Corporation in a report on Sunday, April 23rd. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $91.76.

In other Danaher Corporation news, SVP Angela S. Lalor sold 10,815 shares of the company’s stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the transaction, the senior vice president now owns 39,020 shares in the company, valued at approximately $3,283,923.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the transaction, the insider now owns 155,520 shares in the company, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. Insiders have sold 38,623 shares of company stock valued at $3,206,426 in the last three months. 12.20% of the stock is currently owned by corporate insiders.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.